Core Viewpoint - Jiangsu Luokai Electromechanical Co., Ltd. has announced the addition of a new implementation location and a delay for its fundraising project related to the manufacturing of new energy and smart distribution network equipment, extending the expected operational date to December 2026 [1][3]. Fundraising Overview - The company issued 4,034,310 convertible bonds at a face value of RMB 100 each, raising a total of RMB 403.431 million, with a net amount of RMB 394.7988 million after deducting issuance costs of RMB 8.6322 million [1][2]. Project Implementation Details - The new implementation location for the project will be at No. 257, Wuyi Road, Lucheng Street, Changzhou Economic Development Zone, where the company plans to relocate production lines for "C-GIS medium voltage circuit breakers" and their accessories to enhance product management and synergy [2][3]. - The project completion date has been postponed from February 2026 to December 2026 due to various uncontrollable factors affecting construction progress, including the need for equipment installation and debugging at the new site [3][4]. Impact of Delay - The decision to add a new implementation location and delay the project is seen as a prudent move to optimize internal resource allocation and improve the efficiency of fundraising utilization, without changing the investment content, total investment amount, or implementation entity [3][4]. Review Procedures - The Audit Committee and the Board of Directors have reviewed and approved the proposal to add a new implementation location and delay the project, confirming that it aligns with the company's operational needs and does not harm shareholder interests [4][6].

Core Viewpoint - The company has approved the completion of the "Heyuan New Energy Magnetic Integrated Device Intelligent Manufacturing Project" and plans to permanently supplement working capital with surplus funds from the project [1] Group 1: Project Completion - The fifth meeting of the fifth board of directors was held on January 27, 2026, where the completion of the project was approved [1] - The project has reached the predetermined usable state as of December 31, 2025 [1] Group 2: Financial Details - Surplus funds amounting to 16.38 million yuan (including cash management income and interest) have been identified from the project [1] - Approximately 15.07 million yuan will be reserved for paying outstanding contract amounts, while the remaining surplus will be used to supplement working capital [1] - The company will close the corresponding fundraising account after all project funds have been utilized [1]

Core Viewpoint - Chengdu Kanghua Biological Products Co., Ltd. has announced a prudent adjustment to the implementation schedule of its fundraising project "Vaccine Production Expansion Project," moving the expected completion date from December 31, 2025, to June 30, 2026 [1][2] Group 1: Project Adjustment Details - The adjustment only involves the project timeline and does not change the implementation entity, location, or the use of raised funds [1] - The project has completed workshop construction, equipment debugging, trial production, drug registration site inspection, GMP compliance checks, and is currently in the supplementary application review stage [1] Group 2: Regulatory and Management Insights - The adjustment is not due to project obstacles but is a necessary coordination with regulatory processes [2] - The company aims to ensure that the project operates in a fully compliant and stable manner by dynamically optimizing expectations based on actual approval rhythms [2] Group 3: Strategic Importance - The expansion project is a strategic move for Kanghua Biological to solidify core production capacity and align with future market demands [2] - Despite the short-term schedule adjustment, the completion of the main engineering and the most challenging review stages has not affected the long-term strategic value and potential contribution to performance [2]

Core Viewpoint - The company has completed the "TianNeng Heavy Industry WuChuan 150MW Wind Power Project" and the "Jiangsu TianNeng Offshore Wind Power Equipment Manufacturing Base Technical Renovation and Phase II Expansion Project," achieving the predetermined usable status [1] Financial Summary - As of December 10, 2025, the total funds raised for the two projects and supplementary working capital projects amount to 1.356 billion yuan, with a surplus of 155 million yuan [1] - The company plans to permanently supplement the surplus funds into working capital, and the related special accounts will be canceled [1] Approval Process - The matter has been approved by the company's Board of Directors and the Audit Committee, pending review by the shareholders' meeting [1] - The sponsor institution, Zhongtai Securities, has no objections to this decision [1]

Core Viewpoint - The company has completed the investment project "Intelligent Manufacturing Overall Solution R&D and Industrialization Project" funded by the issuance of convertible bonds in 2021, and will conclude this project [1] Group 1: Project Completion and Fund Allocation - The remaining raised funds amounting to 283.4181 million yuan will be allocated to new investment projects and to permanently supplement the working capital of its wholly-owned subsidiary, Dongguan Tuosida Technology Co., Ltd [1] - The new investment project, "CNC Machine Tool R&D and Industrialization Project," has a total investment of 261.5568 million yuan, with 234 million yuan sourced from the raised funds [1] - A small portion of the remaining funds, 49.4181 million yuan (including interest income), will be used to permanently supplement the working capital of Tuosida Technology to meet its daily operational needs [1]

Core Viewpoint - Wanfu Biology has decided to suspend the implementation of certain fundraising projects due to significant changes in the internal and external operating environment, aiming to avoid resource waste and reduce operational costs while maintaining long-term interests for the company and its shareholders [1][3]. Group 1 - The company held its 17th meeting of the 5th Board of Directors on November 14, where it approved the proposal to re-evaluate and suspend the implementation of certain fundraising projects [3]. - The decision to suspend the "Knowledge City Production Base Construction Project" will not change the project’s implementation subject, method, use of raised funds, or investment scale [3].

Core Viewpoint - Beijing Wajinke Information Technology Co., Ltd. has approved the adjustment of surplus fundraising for the "Research and Operation Base Construction Project" to be used for the "Mobile Marketing Service Business Upgrade Project" to enhance fundraising efficiency [1][2] Fundraising Overview - The total amount of funds raised by the company in 2022 was RMB 591.26 million, with actual funds received after deducting issuance costs amounting to RMB 517.08 million [1] - The funds were verified by Rongcheng Accounting Firm and were stored in a dedicated account with a tripartite supervision agreement signed with the supervising bank and sponsor [1] Fundraising Account Cancellation - The fundraising project "Research and Operation Base Construction Project" has been completed, and the company has canceled the corresponding special fundraising account, including interest and investment income [2] - The cancellation procedures for the special fundraising account have been completed, and the relevant supervision agreement has been terminated [2]

Core Viewpoint - The company has decided to re-evaluate and temporarily suspend certain fundraising investment projects due to changes in market conditions and technological advancements in the industry [3][4]. Fundraising Overview - The company raised a total of RMB 815,978,425.74 by issuing 240,134,144 shares at a price of RMB 3.45 per share [1]. - All raised funds have been deposited into a special account approved by the board of directors, with a tripartite supervision agreement signed among the company, the sponsor, and the commercial bank [2]. Investment Project Adjustments - The adjusted investment projects include the key equipment production line for panel boxes and the intelligent transformation project for high-end wear-resistant parts [2]. - The total investment amount for the projects was adjusted from RMB 82,846.28 million to RMB 81,597.84 million, with a total investment of RMB 108,801.61 million [2]. Project Re-evaluation and Suspension - The high-end wear-resistant parts manufacturing line project has been delayed compared to the original plan, requiring a re-evaluation based on the latest industry technologies and market demands [3]. - The decision to suspend the project is based on the evolving industry requirements for materials and processes, which have introduced new materials that differ from the original plan to produce metal liners [3][4]. Impact of Project Suspension - The re-evaluation and suspension of the investment projects are seen as prudent decisions that do not harm shareholder interests and comply with relevant regulations [4][5]. - The company believes that this decision will optimize resource allocation, reduce investment risks, and lay a foundation for future market opportunities [4]. Approval Procedures - The board of directors and the supervisory board have approved the re-evaluation and suspension of the high-end wear-resistant project [5]. - The sponsor has confirmed that the approval procedures comply with the relevant regulations and that the decision does not harm shareholder interests [5][6].

Core Viewpoint - The company has approved its 2025 semi-annual report and related proposals during the board meetings, including a share buyback plan and governance structure revisions [3][9][19]. Group 1: Company Overview - The company is Guangdong DeGuan Film New Materials Co., Ltd., with the stock code 001378 [7]. - The board of directors and the supervisory board have both confirmed the accuracy and completeness of the information disclosed [7][29]. Group 2: Financial and Operational Highlights - The company plans to repurchase shares using its own funds and a special loan for stock repurchase, with a total amount between RMB 20 million and RMB 40 million, and a maximum price of RMB 32.44 per share [5][19]. - As of June 30, 2025, the company has not yet implemented the share buyback [6]. Group 3: Board Meeting Resolutions - The board approved the 2025 semi-annual report and its summary, as well as a special report on the use of raised funds [9][12]. - The board has decided to revise the company's articles of association, eliminating the supervisory board and transferring its powers to the audit committee [14][17]. - The board approved the extension of certain fundraising project deadlines, specifically for the "Functional Film and Functional Masterbatch Expansion and Technical Transformation Project" and the "Laboratory and Testing Upgrade Technical Transformation Project" [19][32]. Group 4: Profit Distribution - The wholly-owned subsidiary, Guangdong DeGuan Packaging Materials Co., Ltd., plans to distribute RMB 100 million in profits to the company, which represents 17.52% of its distributable profits as of June 30, 2025 [22]. Group 5: Upcoming Events - The company will hold its second extraordinary general meeting of 2025 on September 1, 2025 [25].

Core Viewpoint - Aiwai Electronics announced the completion of several fundraising projects and the reallocation of surplus funds to other projects, indicating a strategic shift in investment focus [2] Summary by Relevant Sections - **Completion of Fundraising Projects** - The company has completed and achieved the intended usable status for the projects: "Intelligent Audio Chip R&D and Industrialization," "5G RF Device R&D and Industrialization," and "Motor Driver Chip R&D and Industrialization" [2] - **Reallocation of Surplus Funds** - Surplus funds from the completed projects will be redirected to the "High-Performance Analog Chip R&D and Industrialization Project" [2] - **Project Extension** - The "High-Performance Analog Chip R&D and Industrialization Project" has been approved for an extension [2] - **No Shareholder Meeting Required** - The decisions made regarding the projects do not require submission for shareholder meeting approval [2]